Kendall Bowlin, in Clinton, SC - Marriage & Family Therapist

Kendall Bowlin, is a Marriage & Family Therapist based in Clinton, South Carolina. Kendall Bowlin is licensed to practice in Florida (license number IMT3985) and her current practice location is 302 S Broad St, Clinton, South Carolina. She can be reached at her office (for appointments etc.) via phone at (864) 938-2100.

NPI number for Kendall Bowlin is 1487435269 and her current mailing address is 302 S Broad St, Clinton, South Carolina. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1487435269.

Contact Information

	Kendall Bowlin,
	302 S Broad St, Clinton, SC 29325-2507
	(864) 938-2100
	Not Available

Healthcare Provider's Profile

Full Name	Kendall Bowlin
Gender	Female
Speciality	Marriage & Family Therapist
Location	302 S Broad St, Clinton, South Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1487435269
Provider Enumeration Date: 10/09/2023
Last Update Date: 10/09/2023

Medical Identifiers

Medical identifiers for Kendall Bowlin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487435269	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	IMT3985 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kendall Bowlin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kendall Bowlin, 302 S Broad St, Clinton, SC 29325-2507 Ph: () -	Kendall Bowlin, 302 S Broad St, Clinton, SC 29325-2507 Ph: (864) 938-2100

News Archive

Semuloparin reduces incidence of VTE in orthopedic surgery patients, study finds

An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie.

Study can aid in developing patient-centered interventions for seniors with asthma

Although often considered a childhood health problem, asthma - a chronic inflammatory disease that causes recurrent cough, wheezing and chest tightness or shortness of breath - can cause serious illness for people age 60 and older, and little is known about the triggers of asthma specific to seniors.

GeneNews discloses financial results for third-quarter 2009

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial results for the third quarter-ended September 30, 2009.

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.

Kendall Bowlin, - Couples Therapy in Clinton, SC